Skip to main content
TipRanks
Go Ultimate75% OFF

Orchid Pharma Limited (ORCHPHARMA) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Orchid Pharma Limited has a market cap or net worth of INR 55.82B. The enterprise value is INR 26.49B.

Market Cap
INR 55.82B
Enterprise Value
INR 26.49B

Share Statistics

Orchid Pharma Limited has 59,885,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
59,885,200
Owned by Insiders
―
Owned by Institutions
0.10%

Financial Efficiency

Orchid Pharma Limited’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 0.34%.

Return on Equity (ROE)
0.02
Return on Assets (ROA)
0.01
Return on Invested Capital (ROIC)
0.34%
Return on Capital Employed (ROCE)
0.00
Revenue Per Employee
6.94M
Profits Per Employee
175.77K
Employee Count
1,169
Asset Turnover
0.42
Inventory Turnover
2.55

Valuation Ratios

The current PE Ratio of Orchid Pharma Limited is 544.36. Orchid Pharma Limited’s PEG ratio is -6.06.

PE Ratio
544.36
PS Ratio
5.56
PB Ratio
3.67
Price to FCF
-35.59
Price to Operating Cash Flow
410.20
PEG Ratio
-6.06

Income Statement

In the last 12 months, Orchid Pharma Limited had revenue of 8.11B and earned 205.47M in profits. Earnings per share was 4.05.

Revenue
8.11B
Gross Profit
1.59B
Operating Income
56.76M
Pretax Income
203.55M
Net Income
205.47M
EBITDA
489.22M
Earnings Per Share (EPS)
4.05

Cash Flow

In the last 12 months, operating cash flow was 115.10M and capital expenditures -1.59B, giving a free cash flow of -1.47B billion.

Operating Cash Flow
115.10M
Free Cash Flow
-1.47B
Free Cash Flow per Share
-29.03

Dividends & Yields

Orchid Pharma Limited pays an annual dividend of INR 3.00, resulting in a dividend yield of ―

Dividend Per Share
INR 3.00
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-3.04%
Earnings Yield
0.18%

Stock Price Statistics

Beta
1.05
52-Week Price Change
8.65%
50-Day Moving Average
946.37
200-Day Moving Average
821.79
Relative Strength Index (RSI)
55.12
Average Volume (3m)
6,321

Important Dates

Orchid Pharma Limited upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 14, 2026
Next Earnings Date
Feb 11, 2027
Ex-Dividend Date
Sep 13, 2012

Financial Position

Orchid Pharma Limited as a current ratio of 2.45, with Debt / Equity ratio of 28.16%

Current Ratio
2.45
Quick Ratio
1.53
Debt to Market Cap
0.15
Net Debt to EBITDA
7.27
Interest Coverage Ratio
0.43

Taxes

In the past 12 months, Orchid Pharma Limited has paid -1.92M in taxes.

Income Tax
-1.92M
Effective Tax Rate
-0.01

Enterprise Valuation

Orchid Pharma Limited EV to EBITDA ratio is 96.54, with an EV/FCF ratio of -32.93.

EV to Sales
5.14
EV to EBITDA
96.54
EV to Free Cash Flow
-32.93
EV to Operating Cash Flow
421.26

Balance Sheet

Orchid Pharma Limited has INR 832.11M in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 832.11M billion.

Cash & Marketable Securities
INR 832.11M
Total Debt
INR 0.00
Net Cash
INR 832.11M
Net Cash Per Share
INR 13.90
Tangible Book Value Per Share
INR 253.91

Margins

Gross margin is 25.73%, with operating margin of 4.42%, and net profit margin of 0.92%.

Gross Margin
25.73%
Operating Margin
4.42%
Pretax Margin
1.23%
Net Profit Margin
0.92%
EBITDA Margin
5.33%
EBIT Margin
1.32%

Analyst Forecast

The average price target for Orchid Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
10.83%
EPS Growth Forecast
-89.83%

Scores

Smart Score
―
AI Score
57